Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study
Submitted by mike kraft on
...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.
...